Intravenous Immunoglobulin (IVIg) Market Futuristic Pharmaceuticals Industry [2019-2023] with Size, Share, Growth, Trend, Outlook Forecast to 2023

MRFR Offers A Thorough Analysis Of Intravenous Immunoglobulin (Ivig) Market Provides The Latest Information On The Present And The Future Industry Trends, Allowing The Readers To Identify The Products And Services, Hence Driving The Revenue Growth And Profitability.

PUNE, India - July 16, 2019 /MarketersMedia/ —

Market overview :

MRFR asserts that the global intravenous immunoglobulin market growing further will Reach USD 8337.2 MN By 2023, Registering Approximately 5.9% CAGR From 2017 To 2023. 

Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies by the human body to fight out the immune deficiency, and the ensuing infectious attacks.

Considering the kind of the growth the market perceives currently; Market Research Future (MRFR) has recently published a study report giving out the complete market forecast up to 2023. In its analysis, Immunodeficiency disorder could be a hereditary issue (Primary disorders), or caused due to the exposure to infections, mainly through bodily fluids, along with the cancer drugs and chemotherapy, aging is one of the key risk factors too that could put someone at higher risk of a damaged immune system.

People nowadays are increasingly adopting heady & unhealthy lifestyles which mirror the prevalence of damaged immune system. Factors such as immense stress, lack of good quality sleep, inadequate & improper diet and sedentary lifestyle are fuelling the prevalence of immunodeficiency disorder and therefore, predominantly driving the growth of the market. 

Fill Out Details To Receive FREE Sample Here: @ https://www.marketresearchfuture.com/sample_request/3137
Major Players:

Key players leading the global IVIg market include Baxter (US), BDI Pharma (US), Abeona Therapeutics (US), China Biologic Products, Inc. (China), Grifols Inc. (Spain), Biotest AG. (Germany), CSL Behring (US), Octapharma (Switzerland), Kedrion S.p.A (US), and Shire (Republic of Ireland) among others.

Industry, Innovation & Related News

March 28, 2019 --- CSL Behring (the US), a leading global biotherapeutics and biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products announced the receiving of an approval from Japan's Ministry of Health, Labour and Welfare has for two of its immunoglobulin therapies - named Hizentra and Privigen for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Out of these, Hizentra which was previously approved for the treatment of primary immunodeficiency (PI) is now Japan's first and only subcutaneous immunoglobulin (SCIG) treatment approved for maintenance therapy to treat CIDP.  Privigen, an intravenous immunoglobulin (IVIG), is now approved for both acute and maintenance treatment of CIDP in Japan.  

Global IVIg Market – Segments

For ease of understanding, the market is segmented into three key dynamics: -

By Types                 : IgA, (IgA1 & A2), IgD, IgE, IgG, and IgM.

By Applications   : Chronic Inflammatory Demyelinating, Hypogammaglobulinemia Multifocal Motor Neuropathy, Immunodeficiency Diseases, CVID (common variable immunodeficiency), SCI (severe combined immunodeficiency), Primary Humoral Immunodeficiency, Unknown (idiopathic) Immunodeficiency diseases, Myasthenia Gravis, Guillain-Barre syndrome, MFS (Miller Fisher Syndrome), AMAN (Acute motor axonal neuropathy) and AMSAN (acute motor-sensory axonal neuropathy), Kawasaki disease, and ITP among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

The augmenting demand for alternate immunoglobulin replacement therapies, increasing R&D funding, rapidly developing healthcare infrastructure and increasing healthcare expenditures are major driving forces for the market growth.  Technological advancements transpired in medical science, are fostering the growth of the market exponentially, bringing up new treatment procedures, & medications in the field of IVIg.

Additionally, factors such as growing population and geriatric populace worldwide are fostering market growth. Rapidly developing economy worldwide is providing impetus to the market growth, enabling access to the quality life & improved healthcare. Substantial investments made in the development of IVIg, by the key market players are paying off well, driving the growth of the market.

On the flip side, factors such as low awareness among people about the availability of treatment, the high cost of IVIg management along with the skepticism towards the advancement & efficacies of these treatments among the patients are likely to impede the growth of the Intravenous Immunoglobulin market.

Global Intravenous Immunoglobulin Market – Regional Analysis

The North American region, heading with the presence of a large number of key players and a well-established healthcare sector accounts for the leading market in the global IVIg market.

The US market backed by the high expenditure on healthcare accounts for the largest contributor to the growth of the regional market. Moreover, the increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to market growth.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137

The intravenous immunoglobulin market in the European region accounts for the second-largest market, globally.

The IVIg market in Europe is fostered by the high per capita income and robust healthcare penetration in the region. The strong market growth in countries like Germany & France drives the regional market growth, large scale. Moreover, factors such as the increasing investments in healthcare and the rising number of patients with immune system diseases are helping the market to create a larger revenue pocket.

The Asia Pacific intravenous immunoglobulin market is expected to perceive an exponential growth. Factors such as the vast population and the burgeoning medical treatment market, especially in India & China, drive the growth of the regional market. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the market growth in the region. With the growing Medical Tourism markets in India & Malaysia, the APAC region will register a significant CAGR during the review period.

Global Intravenous Immunoglobulin Market – Competitive Landscape

Fiercely competitive, the global IVIg market appears to be fragmented due to the presence of several large and small players. These players acquire small yet promising companies to expand their reach in the emerging markets, focusing on improving their market performance. The acquisition of local manufactures by multinational companies makes the market structure look dynamic. Strategies such as product innovations and technologies are creating strong investment opportunities for the players.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Contact:, , Market Research Future, , Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India, , +1 646 845 9312, , Email: sales@marketresearchfuture.com
Phone: 646845931
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/intravenous-immunoglobulin-ivig-market-futuristic-pharmaceuticals-industry-2019-2023-with-size-share-growth-trend-outlook-forecast-to-2023/88897013

Source: MarketersMedia

Release ID: 88897013

More News From Sports - The World Insiders

Predators score 5 in second, beat Red Wings 6-1

Dec 16, 2019

DETROIT — Matt Duchene figured the Nashville Predators deserved better after scoring just once in a loss to the New York Rangers over the weekend. He had few complaints two nights later. Duchene scored two of Nashville's five second-period goals, and the Predators easily dispatched the Detroit Red Wings 6-1 on Monday night. One of Duchene's goals came when he flung the puck from along the boards near the blue line. It deflected in off the stick of Red Wings defenseman Madison Bowey. "I thought Saturday we did a lot of good things and probably should have scored that many...

Kane scores in overtime, Blackhawks beat Ducks 3-2

Dec 16, 2019

ANAHEIM, Calif. — Patrick Kane scored 24 second into overtime off a pass from Jonathan Toews and the Chicago Blackhawks beat the Anaheim Ducks 3-2 Sunday night. Rookie Adam Boqvist scored his first career NHL goal and Alex DeBrincat scored on a two-man advantage as the Blackhawks spoiled the 1,000th career game of Ducks center Ryan Getzlaf. Sam Steel and Nick Ritchie scored for Anaheim. Ryan Miller had 34 saves. Toews, stopped in traffic shortly after overtime began, spun around and slipped a cross-ice pass to Kane, who lifted the puck over the shoulder of Miller for the winner. Blackhawks...

Tkachuk's trickery sends Flames past Predators 6-5 in OT

Dec 16, 2019

NASHVILLE, Tenn. — Matthew Tkachuk didn't think a comeback win was possible after Calgary's terrible start. Then, he scored a pair of improbable goals for a come-from-behind win. Tkachuk scored the tying goal with 40 seconds left in regulation and the winning goal with 1.4 seconds left in overtime on a between-the-legs shot as the Flames' beat the Nashville Predators 6-5 on Thursday night. Calgary rallied from a three-goal deficit after Nashville took the game's first 14 shots. "I didn't think it was going to be possible after the first 20 minutes or first 10 minutes," Tkachuk said. "We were...

Blues' Tarasenko to miss weekend games at Boston, Detroit

Dec 16, 2019

ST. LOUIS — Blues forward Vladimir Tarasenko will not travel with the team for weekend games at Boston and Detroit after suffering an unspecified upper-body injury in a win over Los Angeles. General manager Doug Armstrong said Friday that Tarasenko will be re-evaluated when the team returns following Sunday's game against the Red Wings. Tarasenko left Thursday night's 5-2 win over the Kings after getting tangled up with Kings defenseman Sean Walker on a partial break with about 6 minutes left in the first. Tarasenko, who had eight points in his previous five games, had two shots in 4:37 of...

Hedman scores late goal, Lightning beat Penguins 3-2

Dec 16, 2019

TAMPA, Fla. — Victor Hedman scored a power-play goal with 56.8 seconds remaining to give the Tampa Bay Lightning a 3-2 victory over the Pittsburgh Penguins on Wednesday night. The defenseman scored from just inside the blue line off Steven Stamkos' pass from the left circle. Alex Killorn and Cedric Paquette also scored, and Andrei Vasilevskiy made 37 saves, including a pair of in-close chances in the final seconds of regulation. One of them, taken by Kris Letang, required a lengthy video review before it was confirmed that the puck didn't cross the goal line. Brandon Tanev and Jake Guentzel...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!